Multiplexed Detection of Breast Cancer-Specific miRNA and Protein Biomarkers on Exosomes Using a Microfluidic Platform
Analytical Chemistry · 04.08.2026 · 98 (30) · 22291-22299
DOI: 10.1021/acs.analchem.6c02416 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 23.07.2026. Verfasst von Hongqiang Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemo and Biosensing, College of Chemistry and Chemical Engineering, Key Laboratory for Bio-Nanotechnology and Molecular Engi…. Hauptthemen laut MEDLINE: MicroRNAs, Exosomes, Biomarkers, Tumor, Breast Neoplasms. Die Arbeit nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China (NSFC), Open Funding of Key Laboratory of Monitoring for Heavy Metal Pollutants, Ministry of Ecology and Environment.
Abstract (Originalsprache)
Exosomes, rich in diverse bioactive molecules, have emerged as a promising “liquid biopsy” approach for early cancer screening. However, relying solely on a single biomarker type can easily lead to missed diagnoses or misjudgments. Therefore, there is an urgent need to develop multiple biomarkers detection strategies to facilitate precise diagnosis. Herein, a microfluidic chip integrating two signals (ALP-driven chemiluminescence and nanobeacons-based fluorescence) into a single device was developed using breast cancer exosomes as a model. A simple sample injection enabled capture and quantitative detection of exosomal surface proteins (CD63, EpCAM, HER2) and internal miRNAs (miRNA-21, miRNA-375). After capture, protein levels were determined by driving magnetic beads and capturing images with a smartphone. Prefabricated nanobeacons were then directly introduced into the chip, enabling miRNA signal detection without RNA extraction. This five-marker biomarker panel achieved a diagnostic accuracy of 99.6% in breast cancer identification, representing an improvement of at least 4.6% over single-marker approaches and an 8.6% increase over any individual biomarker. This multitarget exosome analysis platform may provide a highly sensitive, low-cost, and easily scalable novel tool for breast cancer early diagnosis and treatment efficacy assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemo and Biosensing, College of Chemistry and Chemical Engineering, Key Laboratory for Bio-Nanotechnology and Molecular Engineering of Hunan Province, Hunan University, Changsha410082, China.
ORCID-Profile: Xiaohai Yang, Qing Wang, Kemin Wang
Förderung
- National Natural Science Foundation of China (NSFC)
- Open Funding of Key Laboratory of Monitoring for Heavy Metal Pollutants, Ministry of Ecology and Environment
Zitieren
APA
Wang, H., Liu, H., Luan, Y., Du, B., Wang, J., Yang, Y., Yang, X., Wang, Q., & Wang, K. (2026). Multiplexed Detection of Breast Cancer-Specific miRNA and Protein Biomarkers on Exosomes Using a Microfluidic Platform. Analytical Chemistry, 98(30), 22291-22299. https://doi.org/10.1021/acs.analchem.6c02416
Vancouver
Wang H, Liu H, Luan Y, Du B, Wang J, Yang Y, et al. Multiplexed Detection of Breast Cancer-Specific miRNA and Protein Biomarkers on Exosomes Using a Microfluidic Platform. Analytical Chemistry. 2026;98(30):22291-22299. doi:10.1021/acs.analchem.6c02416
BibTeX
@article{Wang2026,
author = {Wang, Hongqiang and Liu, Hui and Luan, Yanan and Du, Bin and Wang, Jun and Yang, Yu and Yang, Xiaohai and Wang, Qing and Wang, Kemin},
title = {Multiplexed Detection of Breast Cancer-Specific miRNA and Protein Biomarkers on Exosomes Using a Microfluidic Platform},
journal = {Analytical Chemistry},
year = {2026},
volume = {98},
number = {30},
pages = {22291--22299},
doi = {10.1021/acs.analchem.6c02416}
}
EUVIMED